跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CARDIOPLEXOL SOLUCION PARA CARDIOPLEJIA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
CARDIOPLEXOL SOLUCION PARA CARDIOPLEJIA
Approved
STANDARD
CARDIOPLEXOL SOLUCION PARA CARDIOPLEJIA
Taw Pharma (Ireland) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Apr 14, 2025
Approval ID
148cb3ee418e6875
Company
Taw Pharma (Ireland) Limited
Type
Standard
Approval Details
Approval Id
148cb3ee418e6875
Drug Cima Aemps Name
CARDIOPLEXOL SOLUCION PARA CARDIOPLEJIA
Register Number
90285
Holder Company Name
Taw Pharma (Ireland) Limited
Marketing Company Name
Taw Pharma (Ireland) Limited
Holder Company Detail Path
/organization/taw-pharma-ireland-limited
Marketing Company Detail Path
/organization/taw-pharma-ireland-limited
Authorization Date
2025-04-14
Dosage Form
SOLUCION PARA CARDIOPLEJIA
Dose
-
Route Of Administration
VÍA INTRACORONARIA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Taw Pharma (Ireland) Limited
Company Detail Path
/organization/taw-pharma-ireland-limited
Company Information
Pharmaceutical Company Name
TAW PHARMA (IRELAND) LIMITED
Country Name
Ireland
City Name
longford,country_ie
Address
UNIT 15, DAINGEAN HALL
Active Ingredients
PROCAINA HIDROCLORURO
0,3 g
MAGNESIO SULFATO HEPTAHIDRATO
4 g
XILITOL
4,5 g
CLORURO DE POTASIO
0,746 g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Apr 14, 2025
Approval ID
148cb3ee418e6875
Type
Standard
Back to CIMA-AEMPS Approvals